Does neuropathy develop in animal models?

Area of Science:

• Neurology
• Endocrinology
• Pharmacology

Background:

• Peripheral nervous system defects are prevalent in diabetes mellitus patients.
• Diabetic neuropathy affects at least 50% of patients within 25 years of diagnosis.
• Current treatments like insulin for euglycaemia have limitations, and neuropathy symptoms are often intractable.

Purpose of the Study:

• To review the appropriateness of established animal models for diabetic neuropathy.
• To compare animal models with human diabetic neuropathy pathology and pathophysiology.
• To aid in the development of effective treatments for diabetic neuropathy.

Main Methods:

• Literature review of established animal models of diabetic neuropathy.
• Comparative analysis of animal model pathology and pathophysiology against human diabetic neuropathy.
• Discussion on the limitations and strengths of current animal models.

Main Results:

• No single animal model perfectly replicates human diabetic neuropathy.
• Established models offer insights into pathogenesis and therapeutic potential.
• Understanding model limitations is key for accurate research.

Conclusions:

• Animal models are essential tools for investigating diabetic neuropathy.
• Careful consideration of model appropriateness is needed for translational research.
• Further refinement of animal models is necessary for effective treatment development.